Search Results1-16 of  16

  • 平岡 聖樹 ID: 9000255838521

    社団法人日本化学療法学会|PK/PD検討委員会 (2007 from CiNii)

    Articles in CiNii:1

    • 社団法人日本化学療法学会PK/PD検討委員会PK/PD検討委員会:臨床PK/PDガイダンス (案) (2007)
  • 平岡 聖樹 ID: 9000256467466

    ブリストル・マイヤーズ (株) 開発研究部 (2004 from CiNii)

    Articles in CiNii:1

    • 社団法人日本化学療法学会PK/PD検討委員会前臨床PK/PDガイダンス (案) (2004)
  • HIRAOKA MASAKI ID: 9000255931730

    Preclinical Research Laboratories, Bristol-Myers Research Institute Ltd. (1990 from CiNii)

    Articles in CiNii:1

    • MICROBIOLOGICAL ASSAY METHOD OF BMY-28100 AND SOME OTHER CEPHEM ANTIBIOTICS IN SERUM AND TISSUES:DEVELOPMENT OF NEW SAMPLE PREPARATION WITH EVANS' BLUE, A HIGH ALBUMIN BINDING DYE (1990)
  • HIRAOKA MASAKI ID: 9000256175269

    Episome Institute (1989 from CiNii)

    Articles in CiNii:1

    • ANTIBACTERIAL ACTIVITY AND β-LACTAMASE STABILITY OF BMY-28100 (1989)
  • HIRAOKA MASAKI ID: 9000256773254

    Nonclinical Research Laboratories, Bristol Banyu Manufacturing Co., Ltd. (1980 from CiNii)

    Articles in CiNii:1

    • PHARMACOKINETICS OF CEFADROXIL IN RATS:COMPARISON OF FASTING AND NON-FASTING (1980)
  • HIRAOKA MASAKI ID: 9000256773258

    Nonclinical Research Laboratories, Bristol Banyu Manufacturing Co., Ltd. (1980 from CiNii)

    Articles in CiNii:1

    • STUDIES ON PROTEIN BINDING OF CEFADROXIL AND SOME OTHER CEPHALOSPORINS (1980)
  • HIRAOKA MASAKI ID: 9000256773262

    Nonclinical Research Laboratories, Bristol Banyu Manufacturing Co., Ltd. (1980 from CiNii)

    Articles in CiNii:1

    • MICROBIOLOGICAL ASSAY METHOD OF CEFADROXIL IN BIOLOGICAL SPECIMENS (1980)
  • HIRAOKA MASAKI ID: 9000256789455

    Preclinical Research Laboratories, Bristol-Myers Research Institute, Ltd. (1990 from CiNii)

    Articles in CiNii:1

    • PHARMACOKINETICS OF BMY-28100 IN MULTIPLE ADMINISTRATION (1990)
  • HIRAOKA Masaki ID: 9000003097571

    ブリストル・マイヤーズ株式会社研究開発部門開発研究部 (2008 from CiNii)

    Articles in CiNii:4

    • Pharmacokinetics of Sotalol Enantiomers after Single and Repeated Oral Administration of Sotalol Hydrochloride to Rats (1995)
    • Adjustment of cefepime dosage in patients with renal impairment (2005)
    • これからの抗菌薬臨床試験のあり方-PK/PDの活用 (2005)
  • HIRAOKA Masaki ID: 9000020310153

    Drug Evaluation Department of Japan Pharmaceutical Manufacturers Association (2005 from CiNii)

    Articles in CiNii:1

    • A Point of Consider on Credible and Efficient Dose Selection Based on the Exposure-Response Relationship (2005)
  • HIRAOKA Masaki ID: 9000021012687

    Articles in CiNii:1

    • MUTAGENICITY TESTS OF ETOPOSIDE AND TENIPOSIDE (1986)
  • HIRAOKA Masaki ID: 9000253261124

    Biopharmaceutics Lab., Kanagawa Laboratories, Bristol-Myers Squibb Co., Ltd. (1995 from CiNii)

    Articles in CiNii:1

    • Pharmacokinetics of Sotalol Enantiomers after Single and Repeated Oral Administration of Sotalol Hydrochloride to Rats. (1995)
  • HIRAOKA Masaki ID: 9000392651474

    Articles in CiNii:1

    • Determination of New Anticancer Drug, Paclitaxel, in Biological Fluids by High Performance Liquid Chromatography (1994)
  • Hiraoka Masaki ID: 9000256177422

    Episome Institute (1991 from CiNii)

    Articles in CiNii:1

    • ANTIBACTERIAL ACTIVITY OF CEFEPIME AGAINST CEPHALOSPORINASEPRODUCING BACTERIA AND INTERACTIONS WITH CEPHALOSPORINASES (1991)
  • Hiraoka Masaki ID: 9000256177469

    Preclinical Research Laboratories, Bristol-Myers Research Institute (1991 from CiNii)

    Articles in CiNii:1

    • <I>IN VITRO</I> AND <I>IN VIVO</I> ANTIBACTERIAL ACTIVITY AND β-LACTAMASE STABILITY OF CEFEPIME, A NEW PARENTERAL CEPHALOSPORIN (1991)
  • Hiraoka Masaki ID: 9000256467774

    Early Development, PRI Japan, Bristol-Myers K.K. (2005 from CiNii)

    Articles in CiNii:1

    • Adjustment of cefepime dosage in patients with renal impairment (2005)
Page Top